ascopubs.org

SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers

SWOG S1815 was a randomized, open label phase III trial, evaluating gemcitabine, nab-paclitaxel, and cisplatin (GAP) versus gemcitabine and cisplatin (GC) in patients with newly diagnosed advanced ...
ascopubs.org

Paclitaxel, Ifosfamide, and Cisplatin as Initial Salvage Chemotherapy for Germ Cell Tumors: Long-Term Follow-Up and Outcomes for Favorable- and Unfavorable-Risk Disease

Genetic Counseling, Testing, and Family Communication Into Survivorship After Diagnosis of Breast Cancer Patients with GCT who received TIP after cisplatin-based chemotherapy were eligible. Favorable ...
Healio

‘Worth pursuing’: Radiotherapy with carboplatin-paclitaxel similar to cisplatin for HNSCC

Please provide your email address to receive an email when new articles are posted on . Survival outcomes did not differ for patients with HNSCC who received radiotherapy with carboplatin-paclitaxel ...